EDIFY Trademark

Trademark Overview


On Monday, February 22, 2021, a trademark application was filed for EDIFY with the United States Patent and Trademark Office. The USPTO has given the EDIFY trademark a serial number of 90539258. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 17, 2023. This trademark is owned by Mana Therapeutics, Inc.. The EDIFY trademark is filed in the Treatment & Processing of Materials Services, Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

Manufacturing of cell therapy platforms for others that trains T-cells to target multiple tumor associated antigens

Pharmaceutical preparations for the treatment of cancer that educate immune cells, without viral, non-viral or other genetic modifications, to manufacture multi-tumor associated antigen T-cells

Reagents for scientific and research use, namely, for use in the manufacturing process of cell therapy platforms to train T-cells to target multiple tumor associated antigens; biochemical preparations in the form of biochemical platforms for scientific purposes, namely, for the manufacturing of cell therapy that trains T-cells to target multiple tumor associated antigens

Platform as a service (PAAS) featuring biological computer software platforms for developing drug products to improve ability to target tumor cells; Platform as a service (PAAS) featuring biological computer software platforms for research and development of pharmaceuticals for use with cell therapy to manufacture tumor-targeted T-cell products and target tumor-specific antigens without genetic modification
edify

General Information


Serial Number90539258
Word MarkEDIFY
Filing DateMonday, February 22, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 17, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 18, 2022

Trademark Statements


Goods and ServicesManufacturing of cell therapy platforms for others that trains T-cells to target multiple tumor associated antigens
Goods and ServicesPharmaceutical preparations for the treatment of cancer that educate immune cells, without viral, non-viral or other genetic modifications, to manufacture multi-tumor associated antigen T-cells
Goods and ServicesReagents for scientific and research use, namely, for use in the manufacturing process of cell therapy platforms to train T-cells to target multiple tumor associated antigens; biochemical preparations in the form of biochemical platforms for scientific purposes, namely, for the manufacturing of cell therapy that trains T-cells to target multiple tumor associated antigens
Goods and ServicesPlatform as a service (PAAS) featuring biological computer software platforms for developing drug products to improve ability to target tumor cells; Platform as a service (PAAS) featuring biological computer software platforms for research and development of pharmaceuticals for use with cell therapy to manufacture tumor-targeted T-cell products and target tumor-specific antigens without genetic modification

Classification Information


International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateMonday, April 25, 2022
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateSaturday, May 22, 2021
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, May 22, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, May 22, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMana Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBethesda, MD 20816

Party NameMana Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBethesda, MD 20816

Trademark Events


Event DateEvent Description
Saturday, May 22, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 28, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, February 25, 2021NEW APPLICATION ENTERED
Wednesday, September 15, 2021ASSIGNED TO EXAMINER
Thursday, October 28, 2021NON-FINAL ACTION WRITTEN
Thursday, October 28, 2021NON-FINAL ACTION E-MAILED
Monday, April 25, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, April 25, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 25, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 16, 2022FINAL REFUSAL WRITTEN
Friday, August 26, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 26, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 8, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 16, 2022FINAL REFUSAL E-MAILED
Tuesday, August 16, 2022NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, August 26, 2022TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, September 28, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 18, 2022PUBLISHED FOR OPPOSITION
Tuesday, October 18, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 13, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, May 2, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, May 2, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, May 2, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 17, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 17, 2023ABANDONMENT - NO USE STATEMENT FILED